NEW YORK (GenomeWeb News) – Pressure BioSciences yesterday reported first quarter revenue that was virtually flat with the 2007 first quarter and a net loss than more than doubled year over year.
 
The South Easton, Mass.-based maker of pressure cycling products for biomolecular research applications reported revenues of $132,376 for the three-month period ended March 31, compared to revenues of $131,621 for the first quarter of 2007. The company noted that it installed seven PCT Sample Preparation Systems during the quarter.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

While gene therapies may have high price tags, they could be cheaper than the cost of managing disease, according to MIT's Technology Review.

Researchers are looking for markers that indicate which cancer patients may respond to immunotherapies, the Associated Press writes.

In Nature this week: paternal age associated with de novo mutations in children, and more.

Nature News writes that researchers are still wrangling over the role of the p-value.